IP Library Granted Patent US 7,998,510
Granted Patent B2
US 7,998,510 · App. 11/839,474 · Granted Aug 16, 2011

Low dose colonic cleansing system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,998,510
App. No.
11/839,474
Granted
Aug 16, 2011
Kind
B2
Abstract

A method of colonic cleansing that includes administering orally a first dose and a second dose of a liquid osmotic colonic evacuant composition. The second dose includes an amount of the liquid osmotic colonic evacuant composition that is 55% to 95% of the amount of the first dose.

Claims (22)

1. A method of colonic cleansing, comprising:

administering orally a first dose of a liquid osmotic colonic evacuant composition; and

administering orally a second dose of the liquid osmotic colonic evacuant composition,

wherein the second dose comprises an amount of the liquid osmotic colonic evacuant composition that is 60% to 70% of the amount of the first dose of the liquid osmotic colonic evacuant composition.

2. A method of claim 1 , wherein the liquid osmotic colonic evacuant composition comprises a phosphate cathartic.

3. The method of claim 2 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate.

4. The method of claim 3 , wherein the second dose comprises an amount of the phosphate cathartic that is 66% of the amount of the first dose of the phosphate cathartic.

5. The method of claim 3 , wherein the first dose of the phosphate cathartic comprises from 15 to 25 g monobasic sodium phosphate and from 5.5 to 9.4 g dibasic sodium phosphate.

6. The method of claim 3 , wherein the first dose of the phosphate cathartic comprises 20 to 23 g monobasic sodium phosphate and 7.5 to 8.6 g dibasic sodium phosphate.

7. The method of claim 3 , wherein the second dose of the phosphate cathartic comprises from 15 g to 17.50 g monobasic sodium phosphate and from 5.64 g to 6.58 g dibasic sodium phosphate.

8. The method of claim 3 , wherein the phosphate cathartic comprises water.

9. The method of claim 3 , further comprising mixing the phosphate cathartic with a flavorant and a sweetener.

10. The method of claim 3 , further comprising supplying the phosphate cathartic as a concentrate.

11. The method of claim 10 , further comprising mixing the phosphate cathartic with water.

12. The method of claim 3 , further comprising waiting at least three hours between administering the first dose and the second dose.

13. In a method of colonic cleansing including consuming a first and second dose of a liquid osmotic colonic evacuant composition, the improvement comprising the second dose being an amount of the liquid osmotic colonic evacuant composition that is 60% to 70% of the amount of the first dose of the liquid osmotic colonic evacuant composition.

14. The method of claim 13 , wherein the liquid osmotic colonic evacuant composition comprises a phosphate cathartic.

15. The method of claim 14 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate.

16. The method of claim 14 , wherein the first dose of the phosphate cathartic comprises from 15 to 25 g monobasic sodium phosphate and from 5.5 to 9.4 g dibasic sodium phosphate.

17. The method of claim 14 , wherein the first dose of the phosphate cathartic comprises 20 to 23 g monobasic sodium phosphate and 7.5 to 8.6 g dibasic sodium phosphate.

18. The method of claim 14 , further comprising mixing the phosphate cathartic with a flavorant and a sweetener.

19. The method of claim 14 , further comprising waiting at least three hours between administering the first dose and the second dose.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 27, 2017
From: GOLUB CAPITAL MARKETS LLC (F/K/A GCI CAPITAL MARKETS LLC)
To: C. B. FLEET COMPANY, INC.; C.B. FLEET INVESTMENT CORPORATION
Reel/Frame 041102/0595 →
SECURITY INTEREST Recorded Oct 24, 2014
From: C. B. FLEET COMPANY, INCORPORATED; C.B. FLEET INVESTMENT CORPORATION
To: GCI CAPITAL MARKETS LLC, AS AGENT
Reel/Frame 034028/0363 →
RELEASE OF SECURITY INTEREST Recorded Oct 24, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: C. B. FLEET COMPANY, INCORPORATED
Reel/Frame 034032/0851 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 15, 2012
From: C. B. FLEET COMPANY, INCORPORATED
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 027873/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2007
From: CASWELL, MICHAEL L.
To: C.B. FLEET COMPANY, INC.
Reel/Frame 019923/0233 →